HLA Informatics Group

IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex;
Nucleic Acids Research (2003), 31:311-314
available from here

Support for the IMGT/HLA Sequence Database

The work of maintaining and updating the database has been supported in the past by the Imperial Cancer Research Fund, the National Institute of Health, the National Marrow Donor Program (NMDP) and more recently by the Anthony Nolan Trust. Alternate sources of financial support have been sought for the continued maintenance of the database. The Sequence.org initiative at the NMDP has solicited funds from institutions and companies who produce HLA typing reagents, typing systems, and instrumentation or that otherwise utilize these databases in critical components of their business. To learn more about how your business can support the IMGT/HLA Sequence database Web site, please contact: Doug Kingsriter (dkingsri@nmdp.org), The Marrow Foundation.

We are grateful to acknowledge the support of our Lead Sponsor - Histogenetics and the following other sponsors. Current contributors include The Anthony Nolan Trust, American Society for Histocompatibility and Immunogenetics (ASHI), BAG, Biotest, European Federation for Immunogenetics (EFI), Invitrogen, One Lambda, National Marrow Donor Program (NMDP), The Marrow Foundation, Tepnel, Abbott, Innogenetics and Qiagen.

Lead sponsorship:

Further sponsorship:

The IPD-KIR Sequence Database provides a centralised repository for KIR sequences. Killer cell Immunoglobulin-like Receptors or KIRs have been shown to be highly polymorphic at the allelic and haplotypic level. KIRs are members of the immunoglobulin superfamily (IgSF) formerly called Killer cell Inhibitory Receptors. They are composed of two or three Ig-domains, a transmembrane region and cytoplasmic tail which can in turn be short (activatory) or long (inhibitory). The Leukocyte Receptor Complex (LRC) which encodes KIR genes has been shown to be polymorphic, polygenic and complex like the MHC.

The IPD-MHC Sequence Database provides a centralised repository for sequences of the major histocompatibilty complex from a number of different species. Through a number of international collaborations IPD is able to provide the MHC sequences of different species. The sequences provided by each group are curated by experts in the field and then submitted to the central database.

Currently the database includes sequence data from Domestic Dogs, Wolves, Coyotes, Non Human Primates, Cattle, Rats, Domestic Cats, Sheep, Fish and Pigs

For the past 12 years, the Anthony Nolan Research Institute has co-ordinated a study to investigate the effects of matching or mis-matching a number of different genetic markers on the outcome of haematopoietic stem cell transplants (HSCT) using unrelated donors. This study involves a total of 37 transplant centres throughout the United Kingdom. Over this period we have recruited well over 1500 Anthony Nolan Trust volunteer donors and their respective recipients.

We are utilising the material made available by this project in several studies that have significantly furthered our understanding of the effects of matching HLA at high resolution and in particular the role of the HLA-DPB1 gene. In addition to this, we are now beginning to investigate the role of genes other than HLA on transplant outcome as we believe that there may be a significant contribution when these are taken in to consideration together with HLA typing. There are two projects being undertaken at this time. The first is trying to establish the effects of NOD2/CARD15 gene polymorphisms on the outcome of unrelated donor haematopoietic stem cell transplants, while the second is investigating the role of KIR genes.

The Anthony Nolan Trust maintains a register of around 390,000 potential bone marrow donors, each of whom have been typed for some of their HLA genes. This data set represents an ideal source of information for studying the HLA genetic diversity in the different UK ethnic groups represented in the register. We are undertaking a project to characterise the geographical HLA genetic diversity of the UK population using donors of North European origin. The results of this project are aimed at aiding the recruitment strategies currently used by the Trust, by the identification of regions with higher diversity. This will contribute to the integration of a more diverse register, and so increase the chances of a patient finding a compatible donor.

Additionally, we are participants of the 15th International Histocompatibility and Immunogenetics Workshop, Registry Diversity Group, an international working group whose objective is to establish the standards for the analysis of genetic data from bone marrow registers or similar sources.

Steven Marsh, Peter Parham, Linda Barber - presents up-to-date and comprehensive information on the HLA genes in a manner that is accessible to both beginner and expert alike. The focus of the book is on the polymorphic HLA genes (HLA-A, B, C, DP, DQ, and DR) that are typed for in clinical HLA laboratories. Each gene has a dedicated section in which individual entries describe the structure, functions, and population distribution of groups of related allotypes. Fourteen introductory chapters provide a beginners' guide to the basic structure, function, and genetics of the HLA genes, as well as to the nomenclature and methods used for HLA typing. Further information on the HLA FactsBook may be found on the Elsevier site.